1. An interesting report of COVID-19 associated mucormycosis (CAM) cases by two different species of Mucorales.
- Author
-
Kaur H, Kanaujia R, Nayak G, Ramavat AS, Patro S, Ghosh A, Chakrabarti A, and Rudramurthy SM
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Amphotericin B therapeutic use, Antifungal Agents therapeutic use, SARS-CoV-2, COVID-19 complications, Mucorales isolation & purification, Mucorales classification, Mucormycosis diagnosis, Mucormycosis microbiology
- Abstract
During surge of COVID-19-associated mucormycosis (CAM), we identified five cases of CAM where two different species of Mucorales were isolated. All had history of diabetes mellitus and presented with clinical features suggesting rhino-orbital mucormycosis. The patients grew different species from their nasal scraping/biopsy samples, Rhizopus arrhizus, R. homothallicus (n = 2); R. homothallicus, Lictheimia corymbifera (n = 1); R. arrhizus, Mucor spp (n = 1); and L. corymbifera, Apophysomyces variabilis (n = 1). All patients underwent surgical and medical (liposomal amphotericin B) treatment. All, except one growing A. variabilis and L. corymbifera survived. Mixed infection by more than one Mucorales in CAM is unique and warrants epidemiological investigation., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF